| Literature DB >> 32508667 |
Julia Kathrin Baumgart1, Berit Brurok1,2, Øyvind Sandbakk1.
Abstract
Purpose: To compare peak oxygen uptake (VO2peak) between the asynchronous arm crank ergometry (ACE), and synchronous wheelchair ergometry (WERG), wheelchair treadmill (WTR), and upper-body poling (UBP) mode.Entities:
Keywords: aerobic endurance; arm crank ergometer; peak aerobic capacity; upper-body poling; wheelchair ergometer; wheelchair treadmill
Year: 2020 PMID: 32508667 PMCID: PMC7248246 DOI: 10.3389/fphys.2020.00412
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
Criteria for determining the level of evidence based on the quality of the studies included for each modes comparison (adjusted from the criteria provided by van Tulder et al., 2003).
| Strong | Data provided in multiple studies of good methodological quality OR in one study of good methodological quality and multiple studies of moderate methodological quality |
| Moderate | Data provided in multiple studies of moderate methodological quality OR in one study of good methodological quality |
| Limited | Data provided in one study of moderate methodological quality |
| Very limited | Data provided in one study of low quality |
Figure 1Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flowchart depicting the study identification, screening, eligibility and inclusion process. VO2peak, Peak oxygen uptake; ACE, arm crank ergometry; WERG, wheelchair ergometry; WTR, wheelchair treadmill; UBP, upper-body poling.
Figure 2Quality scores of the 19 included studies. Green dots are for items scored Yes, red dots for items scored No and yellow dots for “Partial Yes” (i.e., scoring 1 of the 2 points possible for item 5).
Figure 3ES, Effect size (95% CI range) of the difference in (A) absolute and (B) body-mass normalized VO2peak between the arm crank ergometer vs. wheelchair ergometer mode. The dot size indicates the relative weight of each study in determining the overall effect size.
Figure 4ES, Effect size (95% CI range) of the difference in absolute (A) and body-mass normalized (B) VO2peak between the arm crank ergometer vs. wheelchair ergometer mode. The dot size indicates the relative weight of each study in determining the overall effect size.
Data extraction table.
| Arabi et al. ( | 1.23 ± 0.35 | 1.23 ± 0.19 | 19.0 ± 5.2 | 19.2 ± 4.3 | 78 ± 19 | ns | Moderate |
| Bloemen et al. ( | ns | ns | 19.5 ± 4.4 | 23.1 ± 7.3 | ns | ns | Moderate |
| Gayle et al. ( | 1.95 ± 0.35 | 1.98 ± 0.39 | ns | ns | ns | ns | Moderate |
| Glaser et al. ( | 1.77 ± 0.56 | 1.73 ± 0.56 | ns | ns | ns | ns | Moderate |
| Hintzy et al. ( | ns | ns | 38.9 ± 4.0 | 34.5 ± 3.6 | 111 ± 10 | 79 ± 12 | Moderate |
| Martel et al. ( | 1.88 ± 0.62 | 1.9 ± 0.63 | ns | ns | 97 ± 25 | 74 ± 19 | Moderate |
| Morgan et al. ( | 1.2 ± 0.25 | 1.4 ± 0.31 | 15.9 ± 2.0 | 18.1 ± 2.3 | 61 ± 13 | 62 ± 17 | Moderate |
| Pohlman et al. ( | 1.95 ± 0.46 | 1.94 ± 0.39 | 27.5 ± 6.2 | 27.3 ± 7.7 | ns | ns | Low |
| Price and Campbell ( | 1.90 ± 0.4 | 1.96 ± 0.4 | 29.7 ± 8.2 | 31.5 ± 8.8 | 125 ± 24 | 55 ± 31 | Moderate |
| Sedlock et al. ( | 1.27 ± 0.29 | 1.19 ± 0.19 | ns | ns | 63 ± 4 | 35 ± 2 | Moderate |
| Simard et al. ( | 0.83 ± 0.28 | 0.80 ± 0.27 | 13.0 ± 4.6 | 12.2 ± 4.7 | 23 ± 16 | 14 ± 17 | Moderate |
| Tørhaug et al. ( | 2.2 ± 0.4 | 2.2 ± 0.4 | 27.3 ± 5.7 | 27.4 ± 6.7 | 130 | 100 | Moderate |
| Wicks et al. ( | 1.41 ± 0.21 | 1.42 ± 0.22 | ns | ns | ns | ns | Low |
| Wicks et al. ( | 0.93 ± 0.28 | 1 ± 0.35 | 13.7 ± 4.1 | 14.7 ± 5.2 | 34 ± 8 | 8 ± 3 | Good |
| 0.83 ± 0.14 | 0.94 ± 0.29 | 13.1 ± 2.2 | 14.9 ± 4.6 | 43 ± 11 | 8 ± 3 | ||
| 1.62 ± 0.42 | 1.55 ± 0.37 | 23 ± 5.9 | 22 ± 5.2 | 89 ± 26 | 34 ± 8 | ||
| 1.97 ± 0.42 | 1.95 ± 0.45 | 28 ± 6.2 | 27.8 ± 6.4 | 113 ± 16 | 41 ± 7 | ||
| 1.23 ± 0.12 | 1.08 ± 0.16 | 21.7 ± 8.3 | 17.5 ± 8.3 | 65 ± 16 | 28 ± 5 | ||
| 2.01 ± 0.43 | 2.02 ± 0.54 | 31 ± 6.6 | 31.2 ± 7.6 | 116 ± 19 | 42 ± 7 | ||
| 2.26 ± 0.36 | 2.16 ± 0.28 | 37.7 ± 4.5 | 36.1 ± 4.7 | 121 ± 9 | 40 ± 7 | ||
| Arabi et al. ( | 1.23 ± 0.35 | 1.25 ± 0.38 | 19 ± 5.2 | 19.5 ± 6.1 | 78 ± 19 | ns | Moderate |
| Gass and Camp ( | 1.96 ± 0.47 | 2.21 ± 0.54 | 30.1 ± 6.6 | 33.8 ± 7.9 | ns | ns | Moderate |
| Gass et al. ( | 1.65 ± 0.42 | 1.72 ± 0.30 | 23.8 ± 6.0 | 24.8 ± 5.1 | ns | ns | Moderate |
| McConnell et al. ( | 2.15 ± 0.58 | 2.42 ± 0.68 | 30.3 ± 7.7 | 34.6 ± 9.9 | ns | ns | Moderate |
| Pitetti et al. ( | ns | ns | 31.4 ± 5.7 | 33.4 ± 5.7 | ns | ns | Low |
| Baumgart et al. ( | ns | ns | 40.3 ± 7.3 | 39.5 ± 6.6 | 152 ± 29 | 127 ± 31 | Good |
| ns | ns | 32.7 ± 7.0 | 30.3 ± 6.1 | 146 ± 33 | 118 ± 34 | ||
| Arabi et al. ( | 1.25 ± 0.38 | 1.23 ± 0.19 | 19.5 ± 6.1 | 19.2 ± 4.3 | ns | ns | Moderate |
Absolute (L·min.
VO.
Data extraction table (continued).
| Arabi et al. ( | 13 | 11 | 2 | 0 | 0 | 29.8 ± 8.7 | ns | 11 PARA, 1 AMP, 1 PM | 13 NPA |
| Bloemen et al. ( | 13 | 9 | 4 | 0 | 0 | 13.4 ± 3.5 | 46.2 ± 18.7 | 13 SB | ns |
| Gayle et al. ( | 15 | 15 | 0 | 0 | 3 | 27.0 ± 5.5 | 73.4 ± 14.3 | 15 PARA | 12 PA, 3 A |
| Glaser et al. ( | 16 | 11 | 5 | 10 | 0 | 25.3 ± 3.7 | 66.9 ± 12.6 | 10 AB, 3 SB, 2 SCI, 1 PM | ns |
| Hintzy et al. ( | 15 | 15 | 0 | 15 | 0 | 23 ± 2 | 74.1 ± 6.3 | 15 AB | NPA |
| Martel et al. ( | 20 | 20 | 0 | 0 | 20 | 26.8 ± 7.2 | ns | 20 PARA | 12 PA, 8 A |
| Morgan et al. ( | 10 | 10 | 0 | 0 | 0 | 33 ± 19.6 | 75.7 ± 11.6 | 7 TETRA, 3 PARA/SB | 7 PA, 3 NPA |
| Pohlman et al. ( | 15 | 15 | 0 | 0 | 0 | 27 ± 5.5 | 73.4 ± 14.3 | 15 PARA | ns |
| Price and Campbell ( | 7 | ns | ns | 0 | 7 | 29.3 ± 5.9 | 64.3 ± 1.7 | 7 PARA | 7 A |
| Sedlock et al. ( | 9 | 0 | 9 | 9 | 0 | 24 ± 2.3 | 58.6 ± 9.5 | 9 AB | 9 NPA |
| Simard et al. ( | 50 | 41 | 9 | 0 | ns | 34.1 ± 9.5 | 66.4 ± 12 | 50 TETRA | ns |
| Tørhaug et al. ( | 12 | 12 | 0 | 0 | 0 | 47 ± 9.4 | 82.2 ± 16.8 | 12 PARA | 12 NPA |
| Wicks et al. ( | 7 | 4 | 3 | 2 | 2 | 28.1 ± 4.1 | ns | 2 AB, 2 TETRA, 3 PARA | 7 NPA |
| Wicks et al. ( | 8 | 8 | 0 | 0 | 8 | 28.6 ± 6 | 67.9 ± 14.7 | 8 TETRA | 65 A |
| 5 | 5 | 0 | 0 | 5 | 28.8 ± 4 | 63.3 ± 9.7 | 5 TETRA | ||
| 11 | 11 | 0 | 0 | 11 | 30.2 ± 8 | 70.5 ± 13.6 | 11 PARA/SB | ||
| 10 | 10 | 0 | 0 | 10 | 27.5 ± 7.4 | 70.3 ± 16.9 | 10 PARA/SB | ||
| 4 | 0 | 4 | 0 | 4 | 28.2 ± 7.9 | 61.5 ± 16.9 | 4 PARA/SB | ||
| 17 | 17 | 0 | 0 | 17 | 26.1 ± 6.5 | 64.8 ± 14.1 | 17 PARA/SB | ||
| 10 | 10 | 0 | 0 | 10 | 36 ± 4.7 | 59.9 ± 7.5 | 10 PARA/SB | ||
| Arabi et al. ( | 13 | 11 | 2 | 0 | 0 | 29.8 ± 8.7 | ns | 11 PARA, 1 AMP, 1 PM | 13 NPA |
| Gass and Camp ( | 10 | 10 | 0 | 0 | ns | 30 ± 3.2 | 65.3 ± 10.6 | 8 PARA, 1TM, 1 PM | 10 PA |
| Gass et al. ( | 9 | 9 | 0 | 0 | 0 | 30.8 ± 2.4 | 70.2 ± 10.1 | 8 PARA, 1 TM | 5 NPA, 4 PA |
| McConnell et al. ( | 11 | 11 | 0 | 0 | 0 | 26.0 ± 4.5 | 70.7 ± 8.6 | 11 PARA | ns |
| Pitetti et al. ( | 8 | 8 | 0 | 0 | 0 | 29 ± 2.8 | ns | 7 PARA, 1 AMP | 8 PA |
| Baumgart et al. ( | 11 | 9 | 2 | 11 | 0 | 22.4 ± 2.6 | 78.1 ± 6.2 | 9 AB | 11 A |
| 7 | 6 | 1 | 0 | 0 | 33.8 ± 11.2 | 74.4 ± 12.5 | 5 PARA, 1 SB | 3 PA, 4 A | |
| Arabi et al. ( | 13 | 11 | 2 | 0 | 0 | 29.8 ± 8.7 | ns | 11 PARA, 1 AMP, 1 PM | 13 NPA |
Information on the number of participants, sex, number of able-bodied participants, number of participants who are wheelchair athletes, age (years), body mass (kg), type of disability, physical activity level for each of the studies included per mode comparison. Where applicable, data are presented as means ± SD.
ACE, Arm crank ergometry; WERG, wheelchair ergometry; WTR, wheelchair treadmill; UBP, upper-body poling; participants with: PARA, paraplegia; TETRA, tetraplegia; SCI, participants with a spinal cord injury without specified level of the injury; AMP, participants with amputation; SB, participants with spina bifida; PM, participants with poliomyelitis; TM, participants with transverse myelitis; participants who are: A, athletes; PA, physically active; NPA, not physically active; ns, not specified.
Study included for more than one modes comparison.
Mean_pooled ± SD_pooled of the body mass at two test instances.
only 11 children were able to complete the test.
Data extraction table (continued).
| Arabi et al. ( | Continuous | 10 W | 1 km/h | 10 W/2 min | 1 km/2 min |
| Bloemen et al. ( | Continuous | 10 W | 60–120 rpm | 10 W/2 min | 0.1 torque/min |
| Gayle et al. ( | Discontinuous | ns | ns | ns | 1 km/h/min |
| Glaser et al. ( | Discontinuous | PO at 75% HRpeak | PO at 75% HRpeak | 60 kpm (9.8 W)/min | 60 kpm/min |
| Hintzy et al. ( | Continuous | 20 W | 20 W | 10 W/2 min | 10 W/2 min |
| Martel et al. ( | Discontinuous | 5 W | 5 W | 10 W/min | 10 W/min |
| Morgan et al. ( | Continuous | 10 W | 10 W | 7 W/min | 7 W/min |
| Pohlman et al. ( | Continuous | ns | ns | 8.5 W/min | 1 km/h/min |
| Price and Campbell ( | Continuous | 30 W | 30 W | 5 W/min | 5 W/min |
| Sedlock et al. ( | Discontinuous | 12.5 W | 12.5 W | 12.5 W/6 min | 6 W/6 min |
| Simard et al. ( | Continuous | 0 W | 0 W | 10 W/2 min | 10 W/2 min |
| Tørhaug et al. ( | Continuous | ns | ns | 5–15 W/min | 5–15 W/min |
| Wicks et al. ( | Continuous | 60 rpm | 20 rpm | 100 kpm (16.3 W)/min for PARA or 25–50 kpm (8.2 W)/min for TETRA | 10 rpm/min increments for PARA or 5 rpm/min increments for TETRA |
| Wicks et al. ( | Continuous | 60 rpm | 20 rpm | 100 kpm (16.3 W)/min for PARA or 50 kpm (8.2 W)/min for TETRA | 10 rpm/min increments for PARA or 5 rpm/min increments for TETRA |
| Arabi et al. ( | Continuous | 10 W | 2 km/h, 1.5% | 10 W/2 min | 1 km/h/2 min |
| Gass and Camp ( | Continuous | 30 W | 5 km/h, 0% | 5 W/20 s | 0.5 km/min. +2% at 2 and 6 min |
| Gass et al. ( | Continuous | 20 W | 3.5 km/h, 0% | 5 W/30 s | 0.5 km/h or 0.5% /30 s until 4%, then 0.5 km/h /30 s |
| McConnell et al. ( | Continuous | 0 kpm (0 W), 72 rpm | 3.2 km/h, 0% | 1 kpm/3 min | 2%/3 min |
| Pitetti et al. ( | Continuous | 3.2 km/h | 75 kpm (12.3 W), 50 rpm | 0.8–1.6 km/h increase until 7.2 km/h | 75 kpm (12.3 W)/min |
| Baumgart et al. ( | Continuous | PO of RPE 11 | PO at RPE 11 | 10 W/min | 10 W/min |
| Arabi et al. ( | Continuous | 10 W | 1 km/h | 10 W/2 min | 1 km/2 min |
Type of test protocol (continuous/discontinuous), starting load and increments [speed in kilometer per hour (km/h), incline in percent (%), power output in kilopond-meter (kpm) or watt (W), revolutions per minute (rpm)] for each of the studies included per mode comparison.
Study included for more than one modes comparison.
Recalculated speed in kilometers per hour (km/h) instead of miles per hour (mph).
ACE, Arm crank ergometry; WERG, wheelchair ergometry; WTR, wheelchair treadmill; UBP, upper-body poling; participants with: PARA, paraplegia; TETRA, tetraplegia; PO, power output; HR.
Meta-regression results on the separate influence of participant-related characteristics on differences in VO2peak between the arm crank ergometer (ACE) and the wheelchair ergometer mode (WERG).
| Body mass (kg) | −0.009 [−0.02–0.004] | 0.16 | 0.6 [−0.2–1.4] | 0.15 | 0 | 0 | 0 | 15 |
| % of able-bodied participants | 0.0006 [−0.002–0.003] | 0.60 | 0.007 [−0.06–0.07] | 0.83 | 0 | 0 | 0 | 18 |
| % of participants with a tetraplegia | −0.0005 [−0.002–0.001] | 0.41 | 0.04 [−0.05–0.1] | 0.39 | 0 | 0 | 0 | 18 |
| % of participants who are wheelchair athletes | 0.0005 [−0.001–0.002] | 0.49 | −0.02 [−0.1–0.1] | 0.69 | 0 | 0 | 0 | 17 |
| Body mass (kg) | 0.07 [−0.1–0.3] | 0.43 | −5.0 [−18.6–8.6] | 0.44 | 2.9 | 44 | −11 | 14 |
| % of able-bodied participants | – | – | – | – | – | – | – | – |
| % of participants with a tetraplegia | −0.01[−0.05−0.02] | 0.34 | 0.6 [−1.2−2.4] | 0.50 | 2.2 | 32 | 2 | 15 |
| % of participants who are wheelchair athletes | 0.002 [−0.03−0.04] | 0.91 | −0.1 [−2.4 −2.2] | 0.90 | 3.1 | 40 | −13 | 14 |
Note that there are no coefficients for the influence of % of able-bodied participants on difference in body-mass normalized VO.